Results 51 to 60 of about 105,856 (292)
Clinical Pharmacology &Therapeutics, EarlyView.Despite known risks, opioids are widely used for chronic non‐cancer pain (CNCP). Clinical guidelines now recommend deprescribing, but factors predicting success are poorly understood. This systematic review aimed to identify clinician and patient factors associated with attaining successful opioid dose reduction or discontinuation in adults with CNCP ...
Alessandra C. Marcelo +8 more
wiley +1 more source
First-dollar cost-sharing for skilled nursing facility care in medicare advantage plans
BMC Health Services Research, 2017 Background The initial days of a Medicare-covered skilled nursing facility (SNF) stay may have no cost-sharing or daily copayments depending on beneficiaries’ enrollment in traditional Medicare or Medicare Advantage.
Laura M. Keohane +6 more
doaj +1 more source
Why Medicare Advantage Plans Pay Hospitals Traditional Medicare Prices [PDF]
Health Affairs, 2015 The policy community generally has assumed Medicare Advantage (MA) plans negotiate hospital payment rates similar to those for commercial insurance products and well above those in traditional Medicare. After surveying senior hospital and health plan executives, we found, however, that MA plans nominally pay only 100-105 percent of traditional Medicare
Robert A, Berenson +3 more
openaire +2 more sources
Competitive Bidding in Medicare Advantage [PDF]
, 2009 Outlines a proposed plan to cut healthcare spending through a competitive bidding system for Medicare Advantage plans that pays insurers the average of their submitted bids.
core
Hospice utilization of Medicare beneficiaries in Hawai‘i compared to other states
, 2017 The objective is to examine hospice utilization among Medicare beneficiaries in Hawai‘i compared to other states. Data were from the 2014 Medicare Hospice Utilization and Payment Public Use File, which included information on 4,025 hospice providers ...
Kataoka-Yahiro, Merle +2 more
core +3 more sources
Financial Toxicity Associated with Biological Medicines: A Scoping Review
Clinical Pharmacology &Therapeutics, EarlyView.Financial toxicity, defined as the economic burden experienced by patients due to medication and other healthcare costs and their consequences, such as material, psychosocial and behavioral effects, represents a significant concern for individuals receiving biological medicines.
Laura Sara Maria Saarukka +4 more
wiley +1 more source
Chronic Disease Prevalence and Medicare Advantage Market Penetration
Health Services Research & Managerial Epidemiology, 2015 By March 2015, 30% of all Medicare beneficiaries were enrolled in Medicare Advantage (MA) plans. Research to date has not explored the impacts of MA market penetration on individual or population health outcomes. The primary objective of this study is to
Steven W. Howard +6 more
doaj +1 more source
The Continuing Cost of Privatization: Extra Payments to Medicare Advantage Plans Jump to $11.4 Billion in 2009 [PDF]
, 2009 Outlines the impact of the 2003 increase in payments to private Medicare Advantage plans, efforts to phase out extra payments in order to finance improvements for low-income beneficiaries, and alternative approaches to providing equitable ...
Brian Biles +2 more
core +1 more source
Epilepsia, EarlyView.Abstract Despite advancements in epilepsy care, a substantial diagnostic gap persists, particularly in resource‐limited settings. This narrative review explores the potential of video‐based diagnostics augmented by artificial intelligence (AI) to address this gap by enabling earlier and more accessible seizure detection and classification.
Gadi Miron +7 more
wiley +1 more source
BMC Health Services ResearchBackground In 2025, the US Medicare program is expected to spend over $1.1 trillion taxpayer dollars. A growing trend in the US Medicare program is more beneficiaries electing a private insurer, referred to as Medicare Advantage (MA), to manage their ...
Lisa M. Grabert +2 more
doaj +1 more source